- Business
- Launch One Acquisition Corp. (NASDAQ: LPAA) is a blank check company whose principal business activity is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting opportunities in the life sciences and healthcare sectors. Founded in 2024 and headquartered at 180 Grand Avenue, Suite 1530, Oakland, California, the company completed a $230 million initial public offering in 2024, issuing 20 million units that began separate trading thereafter. The company has no significant current operations and maintains a lean structure led by Chairman Ryan Gilbert, Chief Executive Officer Chris Ehrlich, and Chief Financial Officer Jurgen van de Vyver. In June 2025, Launch One Acquisition Corp. signed a definitive business combination agreement with Minovia Therapeutics Ltd., a clinical-stage biotechnology company developing mitochondrial therapies, aiming to create a Nasdaq-listed entity focused on the mitochondrial and longevity markets. This proposed de-SPAC transaction, advised by firms including Goldfarb Gross Seligman and Ogier, represents the company's primary strategic initiative to date, with no other recent acquisitions, funding rounds, or product launches reported.